“Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes” (2020) Cardiology and Cardiovascular Medicine, 4(6), pp. 736–742. Available at: https://fortunejournals.org/ojs/index.php/ccm/article/view/15983 (Accessed: 18 September 2026).